Skip to Main Content

Author Details

Carl Anthony Blau
Center for Cancer Innovation, University of Washington
1991
95
38
PMIDPaper TitleJournal TitlePublished Year
35294224Safety, Feasibility, and Merits of Longitudinal Molecular Testing of Multiple Metastatic Sites to Inform mTNBC Patient Treatment in the Intensive Trial of Omics in Cancer.JCO Precis Oncol2022
29298978A machine learning approach to integrate big data for precision medicine in acute myeloid leukemia.Nat Commun2018
30277660The RareCyte® platform for next-generation analysis of circulating tumor cells.Cytometry A2018
29382556Using DNase Hi-C techniques to map global and local three-dimensional genome architecture at high resolution.Methods2018
27978570Comparison of 2 Commercially Available Next-Generation Sequencing Platforms in Oncology.JAMA Oncol2017
32913975Participant Attitudes Toward an Intensive Trial of Multiple Biopsies, Multidimensional Molecular Analysis, and Reporting of Results in Metastatic Triple-Negative Breast Cancer.JCO Precis Oncol2017
28135323Human Cord Blood and Bone Marrow CD34+ Cells Generate Macrophages That Support Erythroid Islands.PLoS One2017
29208983Comprehensive statistical inference of the clonal structure of cancer from multiple biopsies.Sci Rep2017
26733551A Distributed Network for Intensive Longitudinal Monitoring in Metastatic Triple-Negative Breast Cancer.J Natl Compr Canc Netw2016
27685100Mapping 3D genome architecture through in situ DNase Hi-C.Nat Protoc2016
25343958A hyperactive Mpl-based cell growth switch drives macrophage-associated erythropoiesis through an erythroid-megakaryocytic precursor.Blood2015
28843283The Proteomic Landscape of Triple-Negative Breast Cancer.Cell Rep2015
26571212The metabolome regulates the epigenetic landscape during naive-to-primed human embryonic stem cell transition.Nat Cell Biol2015
26248554Bipartite structure of the inactive mouse X chromosome.Genome Biol2015
25892236The proteomic landscape of triple-negative breast cancer.Cell Rep2015
25944336High-recovery visual identification and single-cell retrieval of circulating tumor cells for genomic analysis using a dual-technology platform integrated with automated immunofluorescence staining.BMC Cancer2015
25437436Fine-scale chromatin interaction maps reveal the cis-regulatory landscape of human lincRNA genes.Nat Methods2015
25583238Sparse expression bases in cancer reveal tumor drivers.Nucleic Acids Res2015
24623855Derivation of naive human embryonic stem cells.Proc Natl Acad Sci U S A2014
25010360Inferring clonal composition from multiple sections of a breast cancer.PLoS Comput Biol2014
24764577JAK2 expression is associated with tumor-infiltrating lymphocytes and improved breast cancer outcomes: implications for evaluating JAK2 inhibitors.Cancer Immunol Res2014
23102584Can we deconstruct cancer, one patient at a time?Trends Genet2013
22174298The structure and function of chromatin and chromosomes.Pac Symp Biocomput2012
22777837The genome in space and time: does form always follow function? How does the spatial and temporal organization of a eukaryotic genome reflect and influence its functions?Bioessays2012
22776363A genome-wide 3C-method for characterizing the three-dimensional architectures of genomes.Methods2012
22446391HIF1α induced switch from bivalent to exclusively glycolytic metabolism during ESC-to-EpiSC/hESC transition.EMBO J2012
22523197Can intensive longitudinal monitoring of individuals advance cancer research?Oncologist2012
22377897Evaluating surface erythropoietin receptor in multiple myeloma.Leukemia2012
22402491Combination of Sleeping Beauty transposition and chemically induced dimerization selection for robust production of engineered cells.Nucleic Acids Res2012
21508364Quantitative comparison of erythropoietin receptor levels in the epithelial versus endothelial fractions of primary breast tumors.Anticancer Res2011
28160652Corrigendum to "Long-term Regulation of Genetically Modified Primary Hematopoietic Cells in Dogs".Mol Ther2011
21712410HIF induces human embryonic stem cell markers in cancer cells.Cancer Res2011
21326218Long-term regulation of genetically modified primary hematopoietic cells in dogs.Mol Ther2011
20436457A three-dimensional model of the yeast genome.Nature2010
20563259Limitations of a murine transgenic breast cancer model for studies of erythropoietin-induced tumor progression.Transl Oncol2010
20128659Characterization of microRNAs involved in embryonic stem cell states.Stem Cells Dev2010
19544471Evaluating erythropoietin-associated tumor progression using archival tissues from a phase III clinical trial.Stem Cells2009
19341625Histone deacetylase inhibition elicits an evolutionarily conserved self-renewal program in embryonic stem cells.Cell Stem Cell2009
18356813Using gene transfer to circumvent off-target effects.Gene Ther2008
19259284Cancer stem cells, endothelial progenitors, and mesenchymal stem cells: "seed and soil" theory revisited.Gastrointest Cancer Res2008
18314434Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia.JAMA2008
17464082Erythropoietin in cancer: presumption of innocence?Stem Cells2007
17610368Multiarm high-throughput integration site detection: limitations of LAM-PCR technology and optimization for clonal analysis.Stem Cells Dev2007
17761519Self-renewal of human embryonic stem cells requires insulin-like growth factor-1 receptor and ERBB2 receptor signaling.Blood2007
16373691Anatomical compartments modify the response of human hematopoietic cells to a mitogenic signal.Stem Cells2006
17071982Establishment of cell lines that exhibit correct ontogenic stage-specific gene expression profiles from tissues of yeast artificial chromosome transgenic mice using chemically induced growth signals.Methods Mol Biol2006
16902155Growth factor receptors as regulators of hematopoiesis.Blood2006
16916927A comparison of NIH-approved human ESC lines.Stem Cells2006
16018548Controlled-rate freezing of human ES cells.Biotechniques2005
16131492{gamma}-Globin gene expression in chemical inducer of dimerization (CID)-dependent multipotential cells established from human {beta}-globin locus yeast artificial chromosome ({beta}-YAC) transgenic mice.J Biol Chem2005
  • 1 - 50 of 95

Recommended Authors

Xiaosong Huang
Guangzhou University
Career Start Year 2007
Number of shared co-authors 0
Sergei Doulatov
University of Washington
Career Start Year 2002
Number of shared co-authors 0
Guibin Chen
and Blood Institute, National Institutes of Health
Career Start Year 2001
Number of shared co-authors 1
Xiaobing Yu
Heidelberg University
Career Start Year 2000
Number of shared co-authors 0
Stephanie Halene
Smilow Cancer Center, Yale University School of Medicine
Career Start Year 1997
Number of shared co-authors 0
Elias T Zambidis
Institute for Cell Engineering, The Johns Hopkins University School of Medicine
Career Start Year 1996
Number of shared co-authors 2
Yukio Nakamura
RIKEN BioResource Research Center
Career Start Year 1992
Number of shared co-authors 0
Michael W Becker
James P. Wilmot Cancer Institute, University of Rochester Medical Center Rochester
Career Start Year 1992
Number of shared co-authors 1
Jose A Cancelas
Cincinnati Children's Hospital Medical Center
Career Start Year 1990
Number of shared co-authors 3
Jeffrey A Medin
Medical College of Wisconsin
Career Start Year 1990
Number of shared co-authors 0
Linzhao Cheng
Johns Hopkins University School of Medicine
Career Start Year 1989
Number of shared co-authors 1
William L Stanford
Ottawa Hospital Research Institute
Career Start Year 1989
Number of shared co-authors 0
Jana Krosl
The Leucegene Project at Institute for Research in Immunology and Cancer.
Career Start Year 1989
Number of shared co-authors 0
Eric E Bouhassira
Albert Einstein College of Medicine
Career Start Year 1987
Number of shared co-authors 0
Clayton A Smith
University of Colorado, Aurora CO.
Career Start Year 1987
Number of shared co-authors 1
Richard J Jones
Sidney Kimmel Cancer Center, Johns Hopkins University
Career Start Year 1986
Number of shared co-authors 1
Lesley M Forrester
Institute of Regeneration and Repair, The University of Edinburgh
Career Start Year 1984
Number of shared co-authors 0
Toshio Kitamura
The University of Tokyo.
Career Start Year 1984
Number of shared co-authors 2
George Q Daley
Boston Children's Hospital, Harvard Medical School
Career Start Year 1982
Number of shared co-authors 3
Daniel C Link
Washington University School of Medicine
Career Start Year 1982
Number of shared co-authors 1
Timothy J Ley
Washington University School of Medicine
Career Start Year 1982
Number of shared co-authors 0
Stefan Burdach
Technische Universitat Munchen
Career Start Year 1981
Number of shared co-authors 1
Hiromitsu Nakauchi
Advanced Research Institute, Tokyo Medical and Dental University
Career Start Year 1981
Number of shared co-authors 1
Trang Hoang
Department of Biomedical Science and Center for Bio-Nanomaterials, Daegu University
Career Start Year 1981
Number of shared co-authors 0
Luigi Naldini
Vita-Salute San Raffaele University
Career Start Year 1980
Number of shared co-authors 2
John E Dick
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1980
Number of shared co-authors 3
Curt I Civin
Center for Stem Cell Biology & Regenerative Medicine and.
Career Start Year 1976
Number of shared co-authors 2
Owen N Witte
University of California los angeles
Career Start Year 1972
Number of shared co-authors 0
Stuart H Orkin
Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year 1967
Number of shared co-authors 6
Grover C Bagby
Knight Cancer Institute, Oregon Health and Science University
Career Start Year 1966
Number of shared co-authors 0

Collaborators

William Stafford Noble
Co-authored papers 9
George Stamatoyannopoulos
University of Washington
Co-authored papers 9
Jay Shendure
University of Washington
Co-authored papers 7
Su-In Lee
University of Washington
Co-authored papers 5
Brigham H Mecham
Center for Cancer Innovation, University of Washington
Co-authored papers 4
Christof von Kalle
Berlin Institute of Health at Charite-Universitatsmedizin Berlin
Co-authored papers 4
Christine M Disteche
Co-authored papers 4
Michael O Dorschner
University of Washington
Co-authored papers 4
Eric P Kaldjian
Co-authored papers 4
Michael Henke
Medical Center, University of Freiburg
Co-authored papers 2
Elizabeth M Perez
Co-authored papers 2
Robert D Hawkins
Co-authored papers 2
Judit Vill??n
University of Washington
Co-authored papers 2
Stanley Fields
University of Washington
Co-authored papers 2
Muneesh Tewari
University of Michigan ann arbor
Co-authored papers 2
Benjamin A Logsdon
Fred Hutchinson Cancer Research Center
Co-authored papers 2
Kelsey M Haas
J. David Gladstone Institutes
Co-authored papers 2
Janusz Dutkowski
Data4Cure Inc.
Co-authored papers 2
Colin C Pritchard
University of Washington, USA Brotman Baty Institute for Precision Medicine
Co-authored papers 2
Jingchun Zhu
University of California at Santa Cruz
Co-authored papers 2
Cara C Tigue
McMaster University.
Co-authored papers 1
Sara E Barnato
Co-authored papers 1
Rajinder Kaul
Altius Institute for Biomedical Sciences
Co-authored papers 1
Deborah A Nickerson
University of Washington
Co-authored papers 1
Jeremy N Rich
UPMC Hillman Cancer Center, University of Pittsburgh Medical Center
Co-authored papers 1
Benjamin Djulbegovic
Medical University of South Carolina
Co-authored papers 1
Daniel Mark Courtney
University of Texas Southwestern Medical Center
Co-authored papers 1
Job Dekker
University of Massachusetts Chan Medical School
Co-authored papers 1
Piper M Treuting
University of Washington
Co-authored papers 1
Yuliang Wang
Nanjing Medical University
Co-authored papers 1
Release 1.2